Chemed Corporation insider trading
CHEfinancial statementsForm 4 filings on EDGAR102 transactions since Nov 16, 2024
From August 19, 2026 to November 16, 2026, 0 insiders at Chemed Corporation bought $0 of stock in the open market, and 2 sold $6M. Officers and directors accounted for $0 of purchases and $6M of sales. The last reported transaction was a gift by Lee Spencer S on November 13, 2026.
The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through November 16, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.
Stock price and insider activity
Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.
Bought $0Sold $6MAug 19, 2026 – Nov 16, 2026
purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.
Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Nov 13, 2026. Insider data through Nov 16, 2026. Prices are adjusted for splits; transaction values are reported dollars.
Every transaction
102 transactions from November 16, 2024 to November 16, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | Lee Spencer S | executive vice president | gift | 60 | $0.00 | — | 12,871 | Nov 16, 2026 |
| Nov 11, 2026 | Lee Spencer S | executive vice president | open-market sale | 1,000 | $547.61 | $548K | 12,931 | Nov 13, 2026 |
| Nov 3, 2026 | Mcnamara Kevin J | president and CEO, Director | open-market sale | 2,000 | $537.90 | $1M | 82,220 | Nov 5, 2026 |
| Nov 2, 2026 | Lee Spencer S | executive vice president | open-market sale | 920 | $537.17 | $494K | 13,931 | Nov 3, 2026 |
| Sep 30, 2026 | Lee Spencer S | executive vice president | option exercise | 12,099 | $445.35 | $5M | 26,011 | Oct 1, 2026 |
| Sep 30, 2026 | Lee Spencer S | executive vice president | tax withholding | 11,160 | $508.93 | $6M | 14,851 | Oct 1, 2026 |
| Sep 28, 2026 | Mcnamara Kevin J | president and CEO, Director | open-market sale | 2,000 | $513.45 | $1M | 66,418 | Sep 30, 2026 |
| Sep 28, 2026 | Hutton Thomas C | vice president, Director | option exercise | 4,629 | $445.35 | $2M | 37,110 | Sep 29, 2026 |
| Sep 28, 2026 | Hutton Thomas C | vice president, Director | tax withholding | 4,270 | $506.65 | $2M | 32,840 | Sep 29, 2026 |
| Sep 18, 2026 | Mcnamara Kevin J | president and CEO, Director | open-market sale | 2,000 | $501.40 | $1M | 68,418 | Sep 21, 2026 |
| Aug 21, 2026 | Lee Spencer S | executive vice president | open-market sale | 1,000 | $541.04 | $541K | 13,912 | Aug 24, 2026 |
| Aug 21, 2026 | Mcnamara Kevin J | president and CEO, Director | open-market sale | 2,000 | $541.16 | $1M | 70,418 | Aug 24, 2026 |
| Aug 10, 2026 | Judkins Brian C | VP and Chief Legal Officer | option exercise | 6,786 | $445.35 | $3M | 9,222 | Aug 10, 2026 |
| Aug 10, 2026 | Judkins Brian C | VP and Chief Legal Officer | tax withholding | 5,878 | $548.96 | $3M | 3,344 | Aug 10, 2026 |
| Aug 5, 2026 | Wherley Joel L | CEO - Vitas Healthcare | option exercise | 2,599 | $445.35 | $1M | 3,451 | Aug 6, 2026 |
| Aug 5, 2026 | Wherley Joel L | CEO - Vitas Healthcare | tax withholding | 2,270 | $542.62 | $1M | 1,181 | Aug 6, 2026 |
| Aug 3, 2026 | Mcnamara Kevin J | president and CEO, Director | open-market sale | 2,000 | $539.51 | $1M | 70,418 | Aug 4, 2026 |
| Jul 31, 2026 | Mcnamara Kevin J | president and CEO, Director | option exercise | 2,001 | $445.35 | $891K | 92,220 | Aug 4, 2026 |
| Jul 31, 2026 | Mcnamara Kevin J | president and CEO, Director | tax withholding | 19,802 | $529.22 | $10M | 72,418 | Aug 4, 2026 |
| Jul 31, 2026 | Grace Patrick P | Director | open-market sale | 190 | $532.00 | $101K | 3,533 | Aug 3, 2026 |
| Jun 9, 2026 | Lindell Andrea R | Director | open-market sale | 1,347 | $447.33 | $603K | 4,578 | Jun 10, 2026 |
| May 29, 2026 | Walsh George J III | Director | open-market sale | 500 | $437.83 | $219K | 3,209 | May 29, 2026 |
| May 18, 2026 | Walsh George J III | Director | award | 386 | $440.77 | $170K | 3,709 | May 19, 2026 |
| May 18, 2026 | Mount John Meredith Jr. | Director | award | 386 | $440.77 | $170K | 1,316 | May 19, 2026 |
| May 18, 2026 | McCarthy Eileen P | Director | award | 386 | $440.77 | $170K | 1,241 | May 19, 2026 |
| May 18, 2026 | Lindell Andrea R | Director | award | 386 | $440.77 | $170K | 5,925 | May 19, 2026 |
| May 18, 2026 | Heaney Christopher J | Director | award | 386 | $440.77 | $170K | 2,775 | May 19, 2026 |
| May 18, 2026 | Grace Patrick P | Director | award | 386 | $440.77 | $170K | 3,723 | May 19, 2026 |
| May 18, 2026 | DeLyons Ron | Director | award | 386 | $440.77 | $170K | 2,052 | May 19, 2026 |
| May 8, 2026 | Grace Patrick P | Director | open-market sale | 60 | $425.78 | $26K | 3,337 | May 8, 2026 |
| May 1, 2026 | Mcnamara Kevin J | president and CEO, Director | open-market sale | 2,000 | $421.13 | $842K | 90,219 | May 4, 2026 |
| Mar 27, 2026 | Mcnamara Kevin J | president and CEO, Director | open-market sale | 1,500 | $369.37 | $554K | 92,219 | Mar 30, 2026 |
| Mar 12, 2026 | Mcnamara Kevin J | president and CEO, Director | open-market sale | 2,000 | $403.18 | $806K | 93,719 | Mar 13, 2026 |
| Feb 13, 2026 | Lee Spencer S | executive vice president | tax withholding | 154 | $469.56 | $72K | 14,912 | Feb 17, 2026 |
| Feb 13, 2026 | Lee Spencer S | executive vice president | option exercise | 0 | $469.56 | $0 | 15,066 | Feb 17, 2026 |
| Feb 13, 2026 | Lee Spencer S | executive vice president | option exercise | 499 | $469.56 | $234K | 15,066 | Feb 17, 2026 |
| Feb 13, 2026 | Hutton Thomas C | vice president, Director | option exercise | 199 | $469.56 | $93K | 32,553 | Feb 17, 2026 |
| Feb 13, 2026 | Hutton Thomas C | vice president, Director | option exercise | 0 | $469.56 | $0 | 32,553 | Feb 17, 2026 |
| Feb 13, 2026 | Hutton Thomas C | vice president, Director | tax withholding | 72 | $469.56 | $34K | 32,481 | Feb 17, 2026 |
| Feb 13, 2026 | Wherley Joel L | CEO - Vitas Healthcare | tax withholding | 80 | $469.56 | $38K | 852 | Feb 17, 2026 |
| Feb 13, 2026 | Wherley Joel L | CEO - Vitas Healthcare | option exercise | 273 | $469.56 | $128K | 932 | Feb 17, 2026 |
| Feb 13, 2026 | Wherley Joel L | CEO - Vitas Healthcare | option exercise | 0 | $469.56 | $0 | 932 | Feb 17, 2026 |
| Feb 13, 2026 | Witzeman Michael D | VP & Chief Financial Officer | tax withholding | 120 | $469.56 | $56K | 5,953 | Feb 17, 2026 |
| Feb 13, 2026 | Witzeman Michael D | VP & Chief Financial Officer | option exercise | 0 | $469.56 | $0 | 6,073 | Feb 17, 2026 |
| Feb 13, 2026 | Witzeman Michael D | VP & Chief Financial Officer | option exercise | 413 | $469.56 | $194K | 6,073 | Feb 17, 2026 |
| Feb 13, 2026 | Mcnamara Kevin J | president and CEO, Director | option exercise | 2,714 | $469.56 | $1M | 96,911 | Feb 17, 2026 |
| Feb 13, 2026 | Mcnamara Kevin J | president and CEO, Director | option exercise | 0 | $469.56 | $0 | 96,911 | Feb 17, 2026 |
| Feb 13, 2026 | Mcnamara Kevin J | president and CEO, Director | tax withholding | 1,192 | $469.56 | $560K | 95,719 | Feb 17, 2026 |
| Feb 13, 2026 | Judkins Brian C | VP and Chief Legal Officer | option exercise | 0 | $469.56 | $0 | 2,538 | Feb 17, 2026 |
| Feb 13, 2026 | Judkins Brian C | VP and Chief Legal Officer | tax withholding | 102 | $469.56 | $48K | 2,436 | Feb 17, 2026 |
Who the insiders are
Everyone who reported a transaction since November 16, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.
| Insider | Role | Last transaction | Kind | Shares held | Bought, 12 months | Sold, 12 months | Sales under a plan |
|---|---|---|---|---|---|---|---|
| Mcnamara Kevin J | president and CEO, Director | Nov 3, 2026 | open-market sale | 82,220 | — | $8M (9) | 0 of 9 |
| Lee Spencer S | executive vice president | Nov 13, 2026 | gift | 12,871 | — | $2M (3) | 0 of 3 |
| Lindell Andrea R | Director | Jun 9, 2026 | open-market sale | 4,578 | — | $603K (1) | 0 of 1 |
| Walsh George J III | Director | May 29, 2026 | open-market sale | 3,209 | — | $219K (1) | 0 of 1 |
| Grace Patrick P | Director | Jul 31, 2026 | open-market sale | 3,533 | — | $127K (2) | 0 of 2 |
| Judkins Brian C | VP and Chief Legal Officer | Aug 10, 2026 | option exercise | 9,222 | — | — | — |
| Hutton Thomas C | vice president, Director | Sep 28, 2026 | option exercise | 37,110 | — | — | — |
| Witzeman Michael D | VP & Chief Financial Officer | Feb 13, 2026 | tax withholding | 5,953 | — | — | — |
| Westfall Nicholas Michael | Executive Vice President | Aug 4, 2025 | open-market sale | 0 | — | — | — |
| Wherley Joel L | CEO - Vitas Healthcare | Aug 5, 2026 | option exercise | 3,451 | — | — | — |
| Mount John Meredith Jr. | Director | May 18, 2026 | award | 1,316 | — | — | — |
| McCarthy Eileen P | Director | May 18, 2026 | award | 1,241 | — | — | — |
| Heaney Christopher J | Director | May 18, 2026 | award | 2,775 | — | — | — |
| DeLyons Ron | Director | May 18, 2026 | award | 2,052 | — | — | — |
Questions
Are Chemed Corporation insiders buying or selling?
Over the twelve months to November 16, 2026, 5 insiders at Chemed Corporation sold $11M of stock in the open market, all by officers and directors, and no insider bought. Net, insiders sold $11M. Only open-market purchases and sales are counted.
Who sold the most Chemed Corporation stock in the last year?
Mcnamara Kevin J (president and CEO, Director) sold $8M in 9 open-market sales over the twelve months to November 16, 2026.
Do Chemed Corporation executives sell under 10b5-1 plans?
0 of the 16 open-market sales in the last twelve months (0%) were reported as made under a Rule 10b5-1 trading plan, set up in advance. A sale under a plan is still counted as a sale.
What counts as insider buying here?
Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.
More on Chemed Corporation
- Chemed Corporation financial statements
- 1 tracked fund holding CHE
- Insider buying and selling across all companies
- These transactions as JSON
From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.